Suppressing inflammatory cascade by cyclo-oxygenase inhibitors attenuates quinolinic acid induced Huntington's disease-like alterations in rats (Q28580143)

From Wikidata

Jump to navigation Jump to search

scientific article published on February 26, 2011

Language	Label	Description	Also known as
English	Suppressing inflammatory cascade by cyclo-oxygenase inhibitors attenuates quinolinic acid induced Huntington's disease-like alterations in rats	scientific article published on February 26, 2011

Statements

scholarly article

1 reference

PubMed publication ID

31 January 2017

Suppressing inflammatory cascade by cyclo-oxygenase inhibitors attenuates quinolinic acid induced Huntington's disease-like alterations in rats (English)

1 reference

PubMed publication ID

31 January 2017

0 references

Huntington's disease

0 references

author name string

Harikesh Kalonia

1

1 reference

PubMed publication ID

31 January 2017

Anil Kumar

2

1 reference

PubMed publication ID

31 January 2017

language of work or name

0 references

publication date

25 April 2011

1 reference

PubMed publication ID

31 January 2017

26 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21362433

25 November 2024

full work available at URL

https://api.elsevier.com/content/article/PII:S0024320511001068?httpAccept=text/xml

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

https://api.elsevier.com/content/article/PII:S0024320511001068?httpAccept=text/plain

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

1 reference

PubMed publication ID

31 January 2017

88

1 reference

PubMed publication ID

31 January 2017

17-18

1 reference

PubMed publication ID

31 January 2017

784–791

1 reference

PubMed publication ID

31 January 2017

The mitochondria permeability transition pore complex in the brain with interacting proteins - promising targets for protection in neurodegenerative diseases

1

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Systemic approaches to modifying quinolinic acid striatal lesions in rats

2

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Chronic quinolinic acid lesions in rats closely resemble Huntington's disease

3

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

A mechanistic view of mitochondrial death decision pores.

4

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease

5

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Asymmetrical motor behavior in rats with unilateral striatal excitotoxic lesions as revealed by the elevated body swing test

6

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

The quinolinic acid hypothesis in Huntington's chorea

7

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Mitochondrial complex inhibitors preferentially damage substantia nigra dopamine neurons in rat brain slices

8

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Melatonin reduces oxidative neurotoxicity due to quinolinic acid:

9

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Excitotoxic cell death

10

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Quinolinic acid up-regulates chemokine production and chemokine receptor expression in astrocytes.

11

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Effect of cyclooxygenase inhibitors on pentylenetetrazol (PTZ)-induced convulsions: Possible mechanism of action

12

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization

13

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Mitochondrial-dependent apoptosis in Huntington's disease human cybrids.

14

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid

15

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

The dual role of prostaglandin E(2) in excitotoxicity and preconditioning-induced neuroprotection

16

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

MK801 prevents quinolinic acid-induced behavioral deficits and neurotoxicity in the striatum

17

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

19

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Protective effect of cyclooxygenase (COX)-inhibitors against drug-induced catatonia and MPTP-induced striatal lesions in rats

20

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Oxidative stress and neurodegeneration: where are we now?

21

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease

22

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Maximal COX-2 and ppRb expression in neurons occurs during early Braak stages prior to the maximal activation of astrocytes and microglia in Alzheimer's disease

23

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Cyclooxygenase inhibition as a strategy to ameliorate brain injury.

24

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Mitochondrial control of neuron death and its role in neurodegenerative disorders.

25

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Protective effect of rofecoxib and nimesulide against intra-striatal quinolinic acid-induced behavioral, oxidative stress and mitochondrial dysfunctions in rats

27

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Role of Ca2+-independent phospholipase A2gamma in Ca2+-induced mitochondrial permeability transition

30

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase

31

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH.

32

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms

33

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Neuroprotection by the selective cyclooxygenase-2 inhibitor SC-236 results in improvements in behavioral deficits induced by reversible spinal cord ischemia

34

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Polyunsaturated fatty acids, neuroinflammation and well being.

35

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Activated immune system in patients with Huntington's disease

36

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Phenformin suppresses calcium responses to glutamate and protects hippocampal neurons against excitotoxicity

37

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction.

38

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Molecular targets of non-steroidal anti-inflammatory drugs in neurodegenerative diseases.

39

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Evidence against calcium as a mediator of mitochondrial dysfunction during apoptosis induced by arachidonic acid and other free fatty acids

41

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Putative role of neuronal 5-lipoxygenase in an aging brain.

42

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus. Inhibition by a platelet-activating factor antagonist

43

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases

44

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Role of COX-2 in inflammatory and degenerative brain diseases.

45

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegeneration

46

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Prostanoids and inflammation: a new concept arising from receptor knockout mice

47

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Changes of mitochondria membrane potential and cytoplasmic cytochrome C in neuron apoptosis induced by benzo(a)pyrene

48

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha.

50

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

In vivo activation of N-methyl-D-aspartate receptors in the rat hippocampus increases prostaglandin E(2) extracellular levels and triggers lipid peroxidation through cyclooxygenase-mediated mechanisms.

51

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

S-Allylcysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats

52

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Mitochondrial medicine for aging and neurodegenerative diseases

53

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease

54

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Mitochondrial structural and functional dynamics in Huntington's disease

55

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Evidence that quinolinic acid severely impairs energy metabolism through activation of NMDA receptors in striatum from developing rats.

56

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

The quinolinic acid model of Huntington's disease: locomotor abnormalities

57

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

MK-801, an N-methyl-D-aspartate receptor antagonist, blocks quinolinic acid-induced lipid peroxidation in rat corpus striatum

58

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease

59

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain

60

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

II. Excitotoxic models for neurodegenerative disorders

61

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Changes of mitochondria and relocation of the apoptosis-inducing factor during apoptosis

62

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease

63

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study

64

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Neuropharmacology of quinolinic and kynurenic acids

65

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS

66

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Prostaglandins and cyclooxygenases in glial cells during brain inflammation

67

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease.

68

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease

69

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

The negative cell cycle regulator, Tob (transducer of ErbB-2), is involved in motor skill learning

70

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Mechanisms of lipid peroxide formation in animal tissues

71

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Diclofenac, a non-steroidal anti-inflammatory drug, suppresses apoptosis induced by endoplasmic reticulum stresses by inhibiting caspase signaling

72

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Selective inhibition of cyclooxygenase-2 exacerbates methamphetamine-induced dopamine depletion in the striatum in rats

73

1 reference

10.1016/J.LFS.2011.02.020

https://api.crossref.org/works/10.1016/J.LFS.2011.02.020

25 November 2024

Identifiers

10.1016/J.LFS.2011.02.020

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28580143&oldid=2279690958"